These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31963843)

  • 1. Identification and Repurposing of Trisubstituted Harmine Derivatives as Novel Inhibitors of
    Pierson E; Haufroid M; Gosain TP; Chopra P; Singh R; Wouters J
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31963843
    [No Abstract]   [Full Text] [Related]  

  • 2. High throughput screen identifies small molecule inhibitors specific for Mycobacterium tuberculosis phosphoserine phosphatase.
    Arora G; Tiwari P; Mandal RS; Gupta A; Sharma D; Saha S; Singh R
    J Biol Chem; 2014 Sep; 289(36):25149-65. PubMed ID: 25037224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of glucosyl-3-phosphoglycerate phosphatase as a novel drug target against resistant strain of Mycobacterium tuberculosis (XDR1219) by using comparative metabolic pathway approach.
    Uddin R; Zahra NU; Azam SS
    Comput Biol Chem; 2019 Apr; 79():91-102. PubMed ID: 30743161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical characterization of phosphoserine phosphatase SerB2 from Mycobacterium marinum.
    Pierson E; Wouters J
    Biochem Biophys Res Commun; 2020 Oct; 530(4):739-744. PubMed ID: 32782143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the phosphoserine phosphatase MtSerB2 for tuberculosis drug discovery, an hybrid knowledge based /fragment based approach.
    Haufroid M; Volkov AN; Wouters J
    Eur J Med Chem; 2023 Jan; 245(Pt 1):114935. PubMed ID: 36403421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of thiourea-based derivatives as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
    Doğan ŞD; Gündüz MG; Doğan H; Krishna VS; Lherbet C; Sriram D
    Eur J Med Chem; 2020 Aug; 199():112402. PubMed ID: 32417538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MoS
    Raghu MS; Pradeep Kumar CB; Prasad KNN; Prashanth MK; Kumarswamy YK; Chandrasekhar S; Veeresh B
    ACS Comb Sci; 2020 Oct; 22(10):509-518. PubMed ID: 32806898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of potent chemical antituberculosis agents targeting Mycobacterium tuberculosis acetohydroxyacid synthase.
    Jung IP; Ha NR; Lee SC; Ryoo SW; Yoon MY
    Int J Antimicrob Agents; 2016 Sep; 48(3):247-58. PubMed ID: 27451857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of inhibitors against Mycobacterium tuberculosis thiamin phosphate synthase, an important target for the development of anti-TB drugs.
    Khare G; Kar R; Tyagi AK
    PLoS One; 2011; 6(7):e22441. PubMed ID: 21818324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragment-based substrate activity screening method for the identification of potent inhibitors of the Mycobacterium tuberculosis phosphatase PtpB.
    Soellner MB; Rawls KA; Grundner C; Alber T; Ellman JA
    J Am Chem Soc; 2007 Aug; 129(31):9613-5. PubMed ID: 17636914
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and evaluation of heterocycle structures as potential inhibitors of Mycobacterium tuberculosis UGM.
    Maaliki C; Fu J; Villaume S; Viljoen A; Raynaud C; Hammoud S; Thibonnet J; Kremer L; Vincent SP; Thiery E
    Bioorg Med Chem; 2020 Jul; 28(13):115579. PubMed ID: 32546296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of
    Singh S; Khare G; Bahal RK; Ghosh PC; Tyagi AK
    Drug Des Devel Ther; 2018; 12():1065-1079. PubMed ID: 29750019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors.
    Esposito M; Szadocka S; Degiacomi G; Orena BS; Mori G; Piano V; Boldrin F; Zemanová J; Huszár S; Barros D; Ekins S; Lelièvre J; Manganelli R; Mattevi A; Pasca MR; Riccardi G; Ballell L; Mikušová K; Chiarelli LR
    ACS Infect Dis; 2017 Jun; 3(6):428-437. PubMed ID: 28475832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of hydrazone containing thiadiazoles as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
    Doğan H; Doğan ŞD; Gündüz MG; Krishna VS; Lherbet C; Sriram D; Şahin O; Sarıpınar E
    Eur J Med Chem; 2020 Feb; 188():112035. PubMed ID: 31951850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic thiosemicarbazones as a new class of Mycobacterium tuberculosis protein tyrosine phosphatase A inhibitors.
    Sens L; de Souza ACA; Pacheco LA; Menegatti ACO; Mori M; Mascarello A; Nunes RJ; Terenzi H
    Bioorg Med Chem; 2018 Nov; 26(21):5742-5750. PubMed ID: 30389409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
    Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
    Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents.
    Chiarelli LR; Mori M; Barlocco D; Beretta G; Gelain A; Pini E; Porcino M; Mori G; Stelitano G; Costantino L; Lapillo M; Bonanni D; Poli G; Tuccinardi T; Villa S; Meneghetti F
    Eur J Med Chem; 2018 Jul; 155():754-763. PubMed ID: 29940465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of M. tuberculosis SerB2, an essential HAD-family phosphatase, reveals novel properties.
    Yadav GP; Shree S; Maurya R; Rai N; Singh DK; Srivastava KK; Ramachandran R
    PLoS One; 2014; 9(12):e115409. PubMed ID: 25521849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.